Loss of p53 epigenetically modulates epithelial to mesenchymal transition in colorectal cancer.

Autor:	Sharma S; Institute of Bioinformatics and Applied Biotechnology (IBAB), Bangalore, India., Rani H; Institute of Bioinformatics and Applied Biotechnology (IBAB), Bangalore, India., Mahesh Y; Indian Institute of Science (IISc), Bangalore, India., Jolly MK; Indian Institute of Science (IISc), Bangalore, India., Dixit J; HCG Oncology, Bangalore, India., Mahadevan V; Institute of Bioinformatics and Applied Biotechnology (IBAB), Bangalore, India. Electronic address: mviji@ibab.ac.in.
Jazyk:	angličtina
Zdroj:	Translational oncology [Transl Oncol] 2024 May; Vol. 43, pp. 101848. Date of Electronic Publication: 2024 Feb 27.
DOI:	10.1016/j.tranon.2023.101848
Abstrakt:	Epithelial to Mesenchymal transition (EMT) drives cancer metastasis and is governed by genetic and epigenetic alterations at multiple levels of regulation. It is well established that loss/mutation of p53 confers oncogenic function to cancer cells and promotes metastasis. Though transcription factors like ZEB1, SLUG, SNAIL and TWIST have been implied in EMT signalling, p53 mediated alterations in the epigenetic machinery accompanying EMT are not clearly understood. This work attempts to explore epigenetic signalling during EMT in colorectal cancer (CRC) cells with varying status of p53. Towards this, we have induced EMT using TGFβ on CRC cell lines with wild type, null and mutant p53 and have assayed epigenetic alterations after EMT induction. Transcriptomic profiling of the four CRC cell lines revealed that the loss of p53 confers more mesenchymal phenotype with EMT induction than its mutant counterparts. This was also accompanied by upregulation of epigenetic writer and eraser machinery suggesting an epigenetic signalling cascade triggered by TGFβ signalling in CRC. Significant agonist and antagonistic relationships observed between EMT factor SNAI1 and SNAI2 with epigenetic enzymes KDM6A/6B and the chromatin organiser SATB1 in p53 null CRC cells suggest a crosstalk between epigenetic and EMT factors. The observed epigenetic regulation of EMT factor SNAI1 correlates with poor clinical outcomes in 270 colorectal cancer patients taken from TCGA-COAD. This unique p53 dependent interplay between epigenetic enzymes and EMT factors in CRC cells may be exploited for development of synergistic therapies for CRC patients presenting to the clinic with loss of p53. Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu